Guangdong Provincial People's Hospital
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1946-01-01
- Employees
- -
- Market Cap
- -
Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)
Phase 3
- Conditions
- Colorectal CancerLiver Metastasis
- Interventions
- Drug: FOFLOX4
- First Posted Date
- 2009-12-18
- Last Posted Date
- 2009-12-18
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 340
- Registration Number
- NCT01035385
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
Phase 2
- Conditions
- Colorectal CancerPotentially Resectable Liver Metastasis From CRC
- Interventions
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2009-10-19
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 110
- Registration Number
- NCT00997685
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease
Phase 2
- Conditions
- Graft Versus Host Disease
- Interventions
- Biological: Mesenchymal stem cell (MSC)
- First Posted Date
- 2009-09-07
- Last Posted Date
- 2014-08-26
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT00972660
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer
- First Posted Date
- 2008-04-22
- Last Posted Date
- 2008-04-22
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT00663689
Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy
Not Applicable
- Conditions
- Type 2 Diabetes MellitusNephropathy
- Interventions
- First Posted Date
- 2008-04-09
- Last Posted Date
- 2016-08-24
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 170
- Registration Number
- NCT00655330
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2008-02-22
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT00614809
Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)
Phase 2
Completed
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Drug: neoadjuvant gemcitabine/carboplatin therapy
- First Posted Date
- 2008-01-25
- Last Posted Date
- 2013-06-25
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT00600587
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy
Phase 4
Completed
- Conditions
- GlomerulonephritisIGA Nephropathy
- Interventions
- First Posted Date
- 2007-01-24
- Last Posted Date
- 2013-08-28
- Lead Sponsor
- Guangdong Provincial People's Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT00426348
- Locations
- 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
© Copyright 2025. All Rights Reserved by MedPath